Menquadfi vial 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV7W5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,611
Award facts
- Contract value 100% obligated
- $29,611.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,611 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 21, 2026, with completion scheduled for January 22, 2026. The contract covers the supply of Menquadfi Vial 0.5ML, a meningococcal vaccine product, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, leveraging the company's existing Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. (formerly Amerisourcebergen), is a major pharmaceutical distributor and critical federal medical procurement vendor. The company demonstrates extensive capability in fulfilling federal requirements across diverse therapeutic domains, with its portfolio encompassing specialty medications, vaccines, generic and brand-name drugs, and specialized medical supplies. This particular vaccine delivery order reflects the company's ongoing role in supporting the Defense Health Agency and broader military healthcare systems with essential pharmaceutical commodities required for military treatment facilities and personnel health protection initiatives.
Quick answers
Who was awarded contract SPE2DR26FV7W5?
SPE2DR26FV7W5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FV7W5 worth?
The government has obligated $29,611 on SPE2DR26FV7W5.
Is contract SPE2DR26FV7W5 an order under another contract?
Yes. SPE2DR26FV7W5 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7W5 competed?
The extent of competition for SPE2DR26FV7W5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award